Results 81 to 90 of about 5,631 (161)

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension

open access: yes, 2012
Leopoldo Martín Baiza-Durán, Juan Francisco Llamas-Moreno, Clotilde Ayala-BarajasClinical Research Department, Laboratorios Sophia, SA de CV Guadalajara, Jalisco, MéxicoBackground: The purpose of this study was to ...
Llamas-Moreno JF   +2 more
core  

Influence of Topical Brimonidine on Visual Field in Glaucoma

open access: yes, 2001
Purpose We evaluated the efficacy of topical brimonidine in visual field preser vation and/or improvement in eyes undergoing controlled glaucoma. Methods Seventy eyes of patients were trained with two different visual field test strategies: The Octopus ...
C. Ruiz Lapuente   +2 more
core   +1 more source

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost

open access: yesClinical Ophthalmology, 2011
Robert D Fechtner1, Paul Harasymowycz2, Donald R Nixon3, Steven D Vold4, Fiaz Zaman5, Julia M Williams6, David A Hollander61Glaucoma Division, University of Medicine and Dentistry New Jersey, Newark, NJ, USA; 2University of Montreal, Montreal, QC, Canada;
Fechtner RD   +6 more
doaj  

Brimonidine-induced uveitis: The inflammatory aftermath of treatment

open access: yesIndian Journal of Ophthalmology. Case Reports
We report a rare case of late onset brimonidine-associated granulomatous anterior uveitis in a patient with primary open angle glaucoma (POAG). A 57-year-old female presented with insidious onset blurring of vision, redness, glare, and pain in the right ...
Hitisha Mittal   +4 more
doaj   +1 more source

The potential of brimonidine for myopia treatment: Targeting MMP-2 to regulate choroidal thickness and control eye growth

open access: yesHeliyon
Drug treatment studies are a focal point for identifying novel approaches to reduce myopia progression through basic science research. Here, we investigated the effects of various brimonidine administration routes and concentrations on form-deprivation ...
Aiqun Xiang   +8 more
doaj   +1 more source

Brimonidine/Apraclonidine: Anterior Segment Effect

open access: yes, 2010
. This study investigated whether brimonidine tartrate 0.2% and/or apraclonidine 0.5% could alter pupil size and intraocular anterior segment configuration. Methods.
Besada, Eulogio   +3 more
core   +1 more source

Brimonidine Eye Drops within the Reach of Children: A Possible Foe

open access: yesChildren
Brimonidine, a selective alpha-2 adrenergic agonist used for the treatment of open-angle glaucoma, has been shown to cause neurological side effects such as unresponsiveness, lethargy, hypoventilation, and stupor, mimicking opioid toxicity. We report one
Daniela Trotta   +5 more
doaj   +1 more source

Does Topical Brimonidine Tartrate Help NAION?

open access: yes, 2002
Topical brimonidine tartrate has been reported to have a neuroprotective benefit for retinal ganglion cells following experimental elevation of intraocular pressure and optic nerve injury in the rat.
Hilary E. Fazzone, MD; Mark J. Kupersmith, MD
core  

Effect of brimonidine tartrate 0.15% on scotopic pupil: Controlled trial

open access: yes, 2007
Purpose: the aim of this study was to evaluate the duration of the effect of one single dose of brimonidine tartrate 0.15% on pupil diameter, under scotopic conditions, when applied topically in 1 eye of normal subjects.Methods: the eyes of 19 normal ...
Gerente, Vanessa M.   +4 more
core   +1 more source

Brimonidine Protects Auditory Hair Cells from in vitro-Induced Toxicity of Gentamicin

open access: yes, 2017
Brimonidine, an alpha-2 adrenergic receptor (α<sub>2</sub>-AR) agonist, has neuroprotective effects in the visual system and in spiral ganglion neurons.
Maurizio Cortada   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy